Burkina Faso vs Liberia: Hepatitis B surface antigen (HBsAg) prevalence
Burkina Faso
0.7%
in 2024
Liberia
0.7%
in 2024
Burkina Faso rank
43rd
Liberia rank
43rd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Burkina Faso
- Liberia
How they compare
Burkina Faso currently reports 0.7% against 0.7% in Liberia, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Liberia ahead.
Burkina Faso ranks 43rd and Liberia ranks 43rd of 194 countries.
Across the 2 decades both report, Burkina Faso averaged higher in 1 and Liberia in 1.
Head to head by decade
| Decade | Burkina Faso | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.9% | 1.2% | 0.2% | Liberia |
| 2020s | 0.8% | 0.7% | 0.1% | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Burkina Faso or Liberia?
- Burkina Faso, at 0.7% against 0.7% in Liberia as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Burkina Faso and Liberia?
- 0.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Liberia?
- 10 years are reported by both, from 2015 to 2024.
- How do Burkina Faso and Liberia rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Burkina Faso ranks 43rd and Liberia ranks 43rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.